These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 37901864)
21. Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma. Qin Y; Zhang D; Zhang H; Hou L; Wang Z; Yang L; Zhang M; Zhao G; Yao Q; Ling R; Zhang J Cancer Cell Int; 2022 Sep; 22(1):296. PubMed ID: 36175889 [TBL] [Abstract][Full Text] [Related]
22. Integrative analyses of potential biomarkers and pathways for non-obstructive azoospermia. Zhong Y; Chen X; Zhao J; Deng H; Li X; Xie Z; Zhou B; Xian Z; Li X; Luo G; Li H Front Genet; 2022; 13():988047. PubMed ID: 36506310 [No Abstract] [Full Text] [Related]
23. Key molecules associated with thyroid carcinoma prognosis: A study based on transcriptome sequencing and GEO datasets. Bai M; Ke S; Yu H; Xu Y; Yu Y; Lu S; Wang C; Huang J; Ma Y; Dai W; Wu Y Front Immunol; 2022; 13():964891. PubMed ID: 36059514 [TBL] [Abstract][Full Text] [Related]
24. Identification of Key Pathways and Genes Downstream of Insulin-Like Growth Factor 1 in Thyroid Carcinoma. Wang J; Wu L; Lu W; Zhang H; Wu Y Genet Test Mol Biomarkers; 2022 Nov; 26(11):522-531. PubMed ID: 36440844 [No Abstract] [Full Text] [Related]
25. Identification of Hub Genes as Potential Prognostic Biomarkers in Cervical Cancer Using Comprehensive Bioinformatics Analysis and Validation Studies. Xue H; Sun Z; Wu W; Du D; Liao S Cancer Manag Res; 2021; 13():117-131. PubMed ID: 33447084 [TBL] [Abstract][Full Text] [Related]
26. Identifying hub genes of papillary thyroid carcinoma in the TCGA and GEO database using bioinformatics analysis. Wan Y; Zhang X; Leng H; Yin W; Zeng W; Zhang C PeerJ; 2020; 8():e9120. PubMed ID: 32714651 [TBL] [Abstract][Full Text] [Related]
27. Exosome-Mediated Communication in Thyroid Cancer: Implications for Prognosis and Therapeutic Targets. Wang Y; Li Q; Yang X; Guo H; Ren T; Zhang T; Ghadakpour P; Ren F Biochem Genet; 2024 Jun; ():. PubMed ID: 38839646 [TBL] [Abstract][Full Text] [Related]
28. The essential role of forkhead box P4 (FOXP4) in thyroid cancer: a study related to The Cancer Genome Atlas and experimental data. Zhou T; Zhao DW; Ma N; Zhu XY; Chen XH; Luo X; Chen S; Gao QJ Endocr Connect; 2023 Apr; 12(4):. PubMed ID: 36752821 [TBL] [Abstract][Full Text] [Related]
29. LncRNA H19 is a potential biomarker and correlated with immune infiltration in thyroid carcinoma. Sahin Y Clin Exp Med; 2023 Jul; 23(3):841-851. PubMed ID: 35810257 [TBL] [Abstract][Full Text] [Related]
30. Mining Prognostic Biomarkers of Thyroid Cancer Patients Based on the Immune-Related Genes and Development of a Reliable Prognostic Risk Model. Fei H; Han X; Wang Y; Li S Mediators Inflamm; 2023; 2023():6503476. PubMed ID: 37554551 [TBL] [Abstract][Full Text] [Related]
31. Identification of the EMT-Related Genes Signature for Predicting Occurrence and Progression in Thyroid Cancer. Li Q; Jiang S; Feng T; Zhu T; Qian B Onco Targets Ther; 2021; 14():3119-3131. PubMed ID: 34012269 [TBL] [Abstract][Full Text] [Related]
32. Chemokine CCL14 affected the clinical outcome and correlated with immune infiltrates in thyroid carcinoma. Zhang MM; Zhao YD; Li Q; He YJ Histol Histopathol; 2023 Jun; 38(6):695-707. PubMed ID: 36409028 [TBL] [Abstract][Full Text] [Related]
33. Identification of non-coding RNA related prognosis biomarkers based on ceRNA network in thyroid cancer. Fang X; Chen X; Gao J; Tong L Front Genet; 2023; 14():1157438. PubMed ID: 37153003 [No Abstract] [Full Text] [Related]
34. Screening and identification of potential hub genes and immune cell infiltration in the synovial tissue of rheumatoid arthritis by bioinformatic approach. Feng ZW; Tang YC; Sheng XY; Wang SH; Wang YB; Liu ZC; Liu JM; Geng B; Xia YY Heliyon; 2023 Jan; 9(1):e12799. PubMed ID: 36699262 [TBL] [Abstract][Full Text] [Related]
35. Identification and validation of a novel senescence-related biomarker for thyroid cancer to predict the prognosis and immunotherapy. Hong K; Cen K; Chen Q; Dai Y; Mai Y; Guo Y Front Immunol; 2023; 14():1128390. PubMed ID: 36761753 [TBL] [Abstract][Full Text] [Related]
36. An integrated analysis of prognostic and immune infiltrates for hub genes as potential survival indicators in patients with lung adenocarcinoma. Xu Z; Wang S; Ren Z; Gao X; Xu L; Zhang S; Ren B World J Surg Oncol; 2022 Mar; 20(1):99. PubMed ID: 35354488 [TBL] [Abstract][Full Text] [Related]
37. Identification of Hub Genes Associated with Tumor-Infiltrating Immune Cells and ECM Dynamics as the Potential Therapeutic Targets in Gastric Cancer through an Integrated Bioinformatic Analysis and Machine Learning Methods. Liu J; Cheng Z Comb Chem High Throughput Screen; 2023; 26(4):653-667. PubMed ID: 35996248 [TBL] [Abstract][Full Text] [Related]
38. Molecular mechanisms, immune cell infiltration, and potential drugs for prostate cancer. Yan Y; Mao X; Zhang Q; Ye Y; Dai Y; Bao M; Zeng Y; Huang R; Mo Z Cancer Biomark; 2021; 31(1):87-96. PubMed ID: 33780364 [TBL] [Abstract][Full Text] [Related]
39. Increased SEMA6B expression as a potential prognostic and immune cell infiltration biomarker in thyroid cancer patients. Lei Q; Wang Y; Li J; Wang S; Hu Y; Duan L; Huo Y; Wu Y; Liu H Aging (Albany NY); 2023 May; 15(9):3572-3585. PubMed ID: 37155149 [TBL] [Abstract][Full Text] [Related]
40. Identification of a Prognostic 3-Gene Risk Prediction Model for Thyroid Cancer. Zhao H; Zhang S; Shao S; Fang H Front Endocrinol (Lausanne); 2020; 11():510. PubMed ID: 32849296 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]